Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2009;40:369-375
Published online before print December 24, 2008, doi: 10.1161/STROKEAHA.108.529214
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
40/2/369    most recent
STROKEAHA.108.529214v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Simpson, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Simpson, J. E.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Brain Diseases
Related Collections
Right arrow Other Research

(Stroke. 2009;40:369.)
© 2009 American Heart Association, Inc.


Original Contributions

Microarray RNA Expression Analysis of Cerebral White Matter Lesions Reveals Changes in Multiple Functional Pathways

Julie E. Simpson, PhD; Ola Hosny, MD; Stephen B. Wharton, MD; Paul R. Heath, PhD; Hazel Holden; Malee S. Fernando, MD; Fiona Matthews, PhD; Gill Forster, BSc; John T. O'Brien, MD; Robert Barber, MD; Raj N. Kalaria, PhD; Carol Brayne, MD; Pamela J. Shaw, MD; Claire E. Lewis, PhD; Paul G. Ince, MD on behalf of the Medical Research Council Cognitive Function and Ageing Study Neuropathology Group

From Academic Units of Pathology (J.E.S., O.H., S.B.W., M.S.F., G.F., C.E.L., P.G.I.) and Neurology (P.R.H., H.H., P.J.S.), University of Sheffield, Sheffield, UK; MRC Biostatistics Unit (F.M.), Institute of Public Health, Cambridge, UK; Institute for Health and Ageing (J.T.O., R.B., R.N.K.), University of Newcastle upon Tyne, UK; Department of Public Health and Primary Care (C.B.), University of Cambridge, Cambridge, UK.

Correspondence to P. G. Ince, Academic Unit of Pathology, Medical School, Beech Hill Road, Sheffield S10 2RX. E-mail P.G.Ince{at}sheffield.ac.uk

Background and Purpose— White matter lesions (WML) in brain aging are linked to dementia and depression. Ischemia contributes to their pathogenesis but other mechanisms may contribute. We used RNA microarray analysis with functional pathway grouping as an unbiased approach to investigate evidence for additional pathogenetic mechanisms.

Methods— WML were identified by MRI and pathology in brains donated to the Medical Research Council Cognitive Function and Ageing Study Cognitive Function and Aging Study. RNA was extracted to compare WML with nonlesional white matter samples from cases with lesions (WM[L]), and from cases with no lesions (WM[C]) using RNA microarray and pathway analysis. Functional pathways were validated for selected genes by quantitative real-time polymerase chain reaction and immunocytochemistry.

Results— We identified 8 major pathways in which multiple genes showed altered RNA transcription (immune regulation, cell cycle, apoptosis, proteolysis, ion transport, cell structure, electron transport, metabolism) among 502 genes that were differentially expressed in WML compared to WM[C]. In WM[L], 409 genes were altered involving the same pathways. Genes selected to validate this microarray data all showed the expected changes in RNA levels and immunohistochemical expression of protein.

Conclusion— WML represent areas with a complex molecular phenotype. From this and previous evidence, WML may arise through tissue ischemia but may also reflect the contribution of additional factors like blood–brain barrier dysfunction. Differential expression of genes in WM[L] compared to WM[C] indicate a "field effect" in the seemingly normal surrounding white matter.


Key Words: brain ischemia • gene microarray analysis • gene regulation • MRI • neuropathology • white matter disease